Central effects of irbesartan, an AT1 antagonist in rats

Lacour, Colette; Canals, Françoise; Cazaubon, Catherine; Nisato, Dino

doi:10.1016/1043-6618(95)87562-x

Search citation statements

Order By: Relevance

Paper Sections

Select...

Central Nervous System Effects1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

1998

2005

Publication Types

Select...

Article3

Relationship

Self Cite0

Independent3

Authors

Journals

Cited by 3 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…administration (p each < 0.05 vs. controls) ( Table 3). After oral administration, irbesartan significantly reduced both the pressor response to and the dipsogenic effect of A11 (p each < 0.05 vs. controls) (32).…”

Section: Central Nervous System Effectsmentioning

confidence: 99%

A Review of the New Angiotensin II‐Receptor Antagonist Irbesartan

Powell

Reeves

Marino

et al. 1998

Cardiovascular Drug Reviews

View full text Add to dashboard Cite

Section: Central Nervous System Effectsmentioning

confidence: 99%

A Review of the New Angiotensin II‐Receptor Antagonist Irbesartan

Powell

Reeves

Marino

et al. 1998

Cardiovascular Drug Reviews

View full text Add to dashboard Cite

Effects of Losartan and Irbesartan administration on brain angiotensinogen mRNA levels

Pediconi

Martarelli

Fontanazza

et al. 2005

European Journal of Pharmacology

View full text Add to dashboard Cite

Evaluation of the ability of irbesartan to cross the blood–brain barrier following acute intragastric treatment

Polidori¹,

Ciccocioppo²,

Nisato³

et al. 1998

European Journal of Pharmacology

View full text Add to dashboard Cite

Central effects of irbesartan, an AT1 antagonist in rats

Cited by 3 publications

References 0 publications

A Review of the New Angiotensin II‐Receptor Antagonist Irbesartan

A Review of the New Angiotensin II‐Receptor Antagonist Irbesartan

Effects of Losartan and Irbesartan administration on brain angiotensinogen mRNA levels

Evaluation of the ability of irbesartan to cross the blood–brain barrier following acute intragastric treatment

Contact Info

Product

Resources

About